Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

With decreases in stroke admission across Latin America during COVID‐19, it is evident that the pandemic has negatively impacted hospitals’ abilities to manage as many stroke cases as before (Pujol‐Lereis et al., 2022; Clement et al., 2005; Soto et al., 2021; Pujol‐Lereis et al.,

COVID-19 40

COVID-19 Stroke Strokes Hospital 40

Cassling

DECEMBER 16, 2022

It was the event’s second year in person since the start of the COVID-19 pandemic, and attendee numbers are quickly ticking back up now that more and more people have grown comfortable with travel. Every year, the leading minds in imaging gather for the annual Radiological Society of North America meeting in Chicago.

COVID-19 52

COVID-19 Innovation Research Technology 52

SoftCath

DECEMBER 2, 2021

Let us explore how Smart Cath Labs can be advanced in the year 2022 Here we have explored five innovations for new Cath Lab technology, including predictive analytics, augmenting soft-tissue visualisation, robotics, trimming down the usage of X-ray navigation and Digital Cath Lab solutions. The post How to Build Smart Cath Labs in 2022?

Technology 52

Technology Innovation Catheterization Laboratory COVID-19 52

Cardiomatics

JUNE 6, 2024

The system is decentralized with 19 regions and two autonomous provinces responsible for the delivery of health services through Local Health Units (ASLs). years, which has recovered well following a large decline due to COVID in 2020. In terms of healthcare spending, Italy allocates about 9.4%

COVID-19 98

COVID-19 Hospital Outpatient Innovation 98

The British Journal of Cardiology

NOVEMBER 10, 2023

The backlash of COVID-19 and the realisation of the impact of Brexit on NHS staff has become the ‘speed camera’ the NHS needed. The NHS long-term plan couldn’t be more current, but it could perhaps have been more timely.

COVID-19 52

COVID-19 Document Article 52

Open Heart

NOVEMBER 28, 2023

Methods MEDLINE and EMBASE were systematically searched up to 4 November 2022. COVID-19 likely increases relative risk (RR (95% CI)) of myocardial infarction (3.3 (1.0 This systematic review and meta-analysis aimed to estimate the causal effects of RTIs on occurrence of cardiovascular diseases in the general population.

Myocardial Infarction 52

Myocardial Infarction COVID-19 Cardiovascular Disease Thrombosis 52

Open Heart

JUNE 29, 2023

Virtual wards could be the way forward to manage acute AF patients through remote monitoring, especially with the rise in global access to digital telecommunication and the growing acceptance of telemedicine post-COVID-19. Results There were 50 admissions to the virtual ward between January and August 2022.

Atrial Fibrillation 52

Atrial Fibrillation Atrial Flutter COVID-19 Blood Pressure 52

BoardVitals - Cardiovascular

JUNE 5, 2024

However, a commentary in the Journal of the American College of Cardiology has highlighted a concerning trend: pass rates for first-time test takers have fallen from 96% in 2018 to 86% in 2021 and 2022. What is driving this decrease?

COVID-19 52

COVID-19 Education Cardiovascular Disease Certification 52

Wellnest

JANUARY 23, 2024

The state recorded a 29% annual rise compared to 2022, underlining the urgency for effective preventive measures. COVID-19: The global pandemic caused by the novel COVID-19 coronavirus has emerged as an unexpected contributor to the rise in cardiac emergencies.

COVID-19 52

COVID-19 Cardiovascular Disease Risk Factors Blood Pressure 52

Dr. Malcolm Kendrick

OCTOBER 25, 2022

25th October 2022 I have been somewhat quiet recently. Monday, October 24, 2022 8:30 a.m. Hybrid Conference’ : ‘The RNA vaccines against COVID-19 mark the beginning of a technological revolution that will transform the way we treat disease and restore health. I have started about ten blogs, then got bogged down ….

COVID-19 52

COVID-19 Blog Heart Attack Heart attacks 52

Circulation

NOVEMBER 11, 2024

Prior to the COVID-19 pandemic, resuscitation data within the AHS was focused on GWTG-R metrics for reporting only. Descriptive data for GWTG-R 2021-2022 metrics identified gaps in guideline adherence and documentation standards: COA 83%, TTS 56%, and survival to discharge 36%.

Nursing 40

Nursing COVID-19 Education Document 40

Open Heart

FEBRUARY 17, 2024

Design A cross-sectional design with self-administered questionnaire with data collected between October 2021 and September 2022. Methods Patients with confirmed diagnosis of HF were sought for data collection in the community and cardiology clinics through an electronic platform.

Heart Failure 40

Heart Failure Quality of Life ACE Inhibitor COVID-19 40

Stroke Journal

FEBRUARY 1, 2024

This study aims to compare recurrent stroke risk of AC versus AP therapy in the interim from index stroke/TIA to PFO closure in a more limited timeline.Methods:The study design was a retrospective cohort study, including patients discussed at an institution’s multi-disciplinary PFO committee meetings between September 2019 and October 2022.

Outcomes 40

Outcomes COVID-19 Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Countries in the region of interest were categorized into three groups based on stroke and COVID‐19 data. The third cohort (2022) included 4 interns studying Asia, Australia/New Zealand, North America/US, and Latin America. A survey template was created in Phase B, and stakeholders were contacted for data collection.

Research 40

Research COVID-19 Public Health Stroke 40

Frontiers in Cardiovascular Medicine

DECEMBER 8, 2024

This study aims to assess the trends of sepsis-associated CVD mortality rates and variations in mortality based on demographics and regions in the US.MethodsThe Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database was used to identify CVD and sepsis-related deaths from 1999 to 2022.

Cardiovascular Disease 40

Cardiovascular Disease COVID-19 Research Hospital 40

Open Heart

NOVEMBER 14, 2023

Aims COVID-19 can cause severe illness and multiorgan dysfunction. Acute myocardial damage has been detected in a significant portion of patients with COVID-19; therefore, several studies have reported that electrocardiographic findings could be used to evaluate the severalty of COVID-19.

COVID-19 40

COVID-19 Atrial Fibrillation Hospital 40

Dr. Anish Koka

FEBRUARY 6, 2023

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID. But it got worse.

COVID-19 52

COVID-19 Chest Pain Academic Hospital 52

Stroke Journal

JANUARY 30, 2025

Adapting to challenges during the COVID-19 pandemic likely increased the DTCT in acute stroke patients from various sociodemographic backgrounds.Methods:We aimed to identify factors affecting the DTCT time for a cohort of over 23,000 patients between January 2018 and August 2022. 1.57) and post-COVID period (OR 1.46; 95% CI 1.30-1.65)

COVID-19 40

COVID-19 Stroke Strokes Hospital 40

Medical Xpress - ECG

APRIL 4, 2022

A simple electrocardiogram (ECG) can pinpoint hospitalized COVID-19 patients at high risk of death who might need intensive management. That's the finding of a study presented at EHRA 2022, a scientific congress of the European Society of Cardiology (ESC).

COVID-19 40

COVID-19 Hospital Electrocardiogram Risk Factors 40

Journal of the American Heart Association

MARCH 21, 2025

However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.

COVID-19 40

COVID-19 Medicare Cardiogenic Shock Hospital 40

Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

This study evaluates the influence of CPC quality control indicators on mortality risk in STEMI patients receiving primary percutaneous coronary intervention (PPCI) during the COVID-19 pandemic. The study provides guidance for quality care during COVID-19.

Chest Pain 59

Chest Pain Myocardial Infarction COVID-19 Catheterization Laboratory 59

Journal of the American Heart Association

MARCH 3, 2025

Methods and ResultsWe conducted a retrospective cohort study using American Heart Association COVID19 Cardiovascular Disease Registry data from May 2020 to March 2022. BackgroundLimited knowledge exists about prophylactic anticoagulation patterns in patients hospitalized for COVID19.Methods

COVID-19 40

COVID-19 Cardiovascular Disease Hospital 40

Society of Thoracic Surgeons - Critical Care

MARCH 2, 2022

Our work suggests that with appropriately selected patients and aggressive management strategies, the use of ECMO support for severe COVID-19 can result in exceptional early survival, and these patients who leave the hospital without the need for oxygen therapy are very likely to remain alive and well 1 year later,” said Deane E.

COVID-19 40

COVID-19 Cardiothoracic ICU Allied Health 40

Journal of the American Heart Association

MARCH 25, 2025

Excess HCMrelated deaths were estimated during the 2020 to 2022 COVID19 pandemic. HCMrelated mortality trends were compared with nonHCM cardiovascular deaths and allcause deaths.

COVID-19 40

COVID-19 Cardiomyopathy Certification Cardiovascular Disease 40

Dr. Anish Koka

OCTOBER 16, 2022

On October 7th, 6 pm, the Florida Department of Health sent out a bulletin announcing new guidance from Florida Surgeon General Dr. Joseph Ladapo that recommended against males aged 18-39 years of age from receiving mRNA COVID-19 vaccines. that actual journalist Paul Thacker chronicles well.

Public Health 52

Public Health COVID-19 Blood Clot Article 52

Dr. Anish Koka

FEBRUARY 13, 2023

Arthur Reingold, an epidemiology professor at UC-Berkeley, notes that UC also requires immunizations for measles and chickenpox, and people still are dying from COVID at rates that exceed those for influenza. 1, there were more than 400 COVID deaths a day across the U.S. As of Feb. Almost a million followers now.

COVID-19 52

COVID-19 Public Health Pediatrics Chest Pain 52

Stroke Journal

JANUARY 30, 2025

Results:Between October 2022 and December 2023 and after an interruption of the study due to the COVID pandemic, a total of 200 patients from four university stroke centers were included: 41 (20.5%) with stroke mimics, 130 (65.0%) with ischemic stroke (IS), and 29 (14.5%) with hemorrhagic stroke (ICH).

COVID-19 40

COVID-19 Stroke Strokes Ischemia 40

Dr. Anish Koka

SEPTEMBER 24, 2022

Today’s post on the latest COVID vaccine myocarditis paper gets a big assist from the wicked smart data visualization expert Josh Stevenson ( subscribe to his substack !) In August 2021, the CDC began a study to follow-up cases of myocarditis in the age group at highest risk for myocarditis after mRNA COVID-19 vaccination.

COVID-19 52

COVID-19 Hospital Chest Pain Quality of Life 52

Stroke Journal

FEBRUARY 1, 2024

The COVID-19 pandemic developed midway through VIPS II enrollment, creating an opportunity to assess its impact.Methods:At 22 North American sites, we enrolled 205 children (28 days-18 years) with AIS (12/2016 - 1/2022), collected serum samples up to 7 days post-stroke, and measured clinical infection via parental interview.

COVID-19 40

COVID-19 Stroke Strokes Pediatrics 40

Dr. Malcolm Kendrick

JANUARY 29, 2025

The time of COVID-19 (which I shall simply call Covid from here on). Which, I think, remains mission critical, because there are strong signs that those who drove the Covid nonsense are itching to do it all, once more. In the UK we have massive Covid enquiry going on. It came, it went, it is now ancient history.

COVID-19 105

COVID-19 Outcomes 105

Stroke Journal

JANUARY 30, 2025

Background:In 2022, stroke shifted from the fourth to the fifth leading cause of death in the U.S. as COVID-19 temporarily took its place. However, with the onset of COVID-19 in 2020, the rate increased to 27.94, peaking in 2021 at 30.78 In 2022, the rate slightly declined to 28.30

COVID-19 40

COVID-19 Hospital Stroke Strokes 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Stroke Journal

JANUARY 30, 2025

Background:The COVID-19 pandemic disrupted healthcare systems and altered patient behaviors, potentially affecting stroke prevalence and outcomes. This study examines trends in stroke-related hospitalizations by age and sex in California from 2016 to 2022, focusing on the pandemic years (2020-2022).Methods:A

COVID-19 40

COVID-19 Hospital Stroke Strokes 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Stroke Journal

FEBRUARY 1, 2024

Introduction:COVID-19 infection has thus emerged to be a new risk factor for Cerebral Venous Thrombosis (CVT). Our study aimed to compare outcomes of patients diagnosed with CVT within 2 weeks of COVID infection compared to those without COVID-19.Methods:Adult 4.50] compared to CVT without COVID.

COVID-19 40

COVID-19 Outcomes Thrombosis Embolism 40

DAIC

JANUARY 25, 2024

The continuing trend reverses improvements achieved in the decade before the COVID-19 pandemic to reduce mortalities from heart disease and stroke , the leading causes of death in the United States. We wanted to understand whether the concerning trends were temporary or whether they continued through 2022.” from 2010 to 2019.

COVID-19 117

COVID-19 Public Health Heart Disease Chronic Disease 117

Dr. Malcolm Kendrick

NOVEMBER 24, 2022

Even though it rested on completely made-up data: ‘The Lancet will alter its peer review process following the retraction of a paper that cited suspect data linking the controversial drug hydroxychloroquine to increased COVID-19 deaths. ’ Drummond Rennie.

Article 40

Article Research COVID-19 Blog 40